Ilexgenin A (Ile-A) is a triterpenoid from ShanLv Cha with beneficial effects on metabolic homeostasis. This study investigated whether Ile-A could inhibit hepatic de novo fatty acid synthesis via the intervention of the processing of SREBP1 maturation.
The effects of Ile-A on CRTC2 translocation and SREBP1 maturation were investigated in the liver of fasted-refed mice and hepatocytes exposed to saturated fatty acids. The effect of Ile-A on hepatic lipid accumulation was also observed in high fat diet (HFD)-fed mice.
Sec23A and Sec31A are two subunits of COPII complex, and their interaction is essential for the processing of SREBP1 maturation. Ile-A activated AMPK by reducing cellular energy and restrained CRTC2 in the cytoplasm to compete with Sec23A for binding to Sec31A under nutrient-rich conditions. Consequently, Ile-A impaired COPII-dependent SREBP1 maturation via disrupting Sec31A-Sec23A interaction, leading to the inhibition of de novo fatty acid synthesis in the liver. In contrast, mTORC1 phosphorylated Ser136 of CRTC2, facilitating the formation of Sec31A-Sec23A interaction to promote SREBP1 maturation, whereas this action was reversed by Ile-A in an AMPK dependent manner. Ile-A protected CRTC2 function and restrained hepatic lipogenic response in HFD-fed mice, providing in vivo evidence to support the beneficial effects of Ile-A on lipid metabolism.
Ile-A activated AMPK and restrained CRTC2 in the cytoplasm to prevent SREBP1 maturation via impairing COPII function in the liver. This finding suggests that CRTC2 might be a potential node for pharmacological intervention to prevent hepatic lipid deposition.
This article is protected by copyright. All rights reserved.
About The Expert
Yawen Lu
Jingjie Ma
Ping Li
Baolin Liu
Xiaodong Wen
Jie Yang
References
PubMed